Biogen’s Abandonment of Controversial Alzheimer’s Drug Is No Surprise, Experts SayFebruary 6, 2024Alzheimer's & CognitionBusiness of Medicine
Dana-Farber Moves to Retract, Correct Dozens of Cancer Papers Amid AllegationsJanuary 25, 2024Business of Medicine
Oncologists Sound the Alarm About Rise of White BaggingJanuary 18, 2024Mixed TopicsBusiness of Medicine
New Federal Rule for Prior Authorizations a ‘Major Win’ for Patients, DoctorsJanuary 18, 2024Business of Medicine
